Volume : 11, Issue : 03, March – 2024
Title:
PRONIOSOMES OF NOVEL DRUG DELIVERY SYSTEM
Authors :
A.Anusha*, P.jyothirmayi, T.Rajani, B.Satyavathi, P.Saritha, P.Bhavya, T.Deepika
Abstract :
The present article depicts an elaborative study of proniosomes as specialized drug delivery system. Proniosomes are dry formulation of water-soluble carrier particles that are coated with surfactant and can be measured out as needed and dehydrated to form niosomal dispersion immediately before use on brief agitation in hot aqueous media within minutes. Provesicular systems, such as proniosomes which is one of the advancement in nanotechnology minimize problems of vesicular systems such as aggregation, fusion and leakage of drug and provide additional convenience in transportation, distribution, storage and dosing. Conventional vesicular systems such as liposomes and niosomes are particulate in nature and face stability related difficulty. The review article provides an insight about these approaches along with a novel vesicular approach known as proniosomes. This new emerging concept has demonstrated the potential in improving the oral bioavailability, targeting drugs to the specific site and also permeation of drugs across the stratum corneum. It prolongs the existence of the drug in systemic circulation and finally reduces the toxicity. The goal of this study is to introduce and explore proniosomes as a carrier system for various pharmaceutical and cosmeceutical applications
Key words: Proliposomes , Cosmeceutical , Bioavailability ,Permeation , Conventional vescicular system , Nanotechnology.
Cite This Article:
Please cite this article in press A.Anusha et al., Proniosomes Of Novel Drug Delivery System., Indo Am. J. P. Sci, 2024; 11 (03).
Number of Downloads : 10
References:
1.Panchagnula R. Transdermal delivery of drugs. Indian JPharmacol.1997;29:140–56.
2. shivan thakore,vishal gajipara,mrs. Shitalacharga,mr. Jaymin Patel.a seminar on buccal drug delivery system;2013.International Journal of Pharmaceutical Investigation ;March 2012 2(1):2-11:2;Saran kumar das ( Dept.of pharmaceutics).buccal drug delivery system;2018.5,9.
3. Anjali Teresa ( Dept. Of Pharmaceutics). nasal route and drug delivery systems review article:2017.2.
4. k.vijayalakshmi .ocular drug delivery systems:2012. 2,6- 8, 14-15 .
5. Mr.Sagar Kishore savale ( Dept.of. pharmaceutics ).Oral drug delivery systems.2016.
6. mr.sagar Kishore savale ( Dept.of pharmaceutics).pulmonary drug delivery system (PDDS):2016.2 -3 ,11,14-15,17.
7. Poonam p Pawar. sublingual route for systemic drug delivery article: journal of drug delivery and therapeutics.December 2018Journal of Drug Delivery and Therapeutics :8(6-s):340-343.
8. P. Chakradhar ( Dept.of pharmaceutics ) , Danish kurien.Transdermal drug delivery system:2012.3-4,7,28.
9. Nithin kurien.Vaginal drug delivery and Rectal drug delivery systems:2017.3.
10. Sai Lakshmi.Novel drug delivery system:2-3.
11. Saleem Mansoor &Tariq jamshed.Novel drug delivery system:10.
12. Dr.prashant L.pingale,Dr.M.S Gosavi .Controlled drug delivery system:2021.2.
13. Basant kumar sah.Target drug delivery system:2018.5.
14.Dr. Shreeraj Shah ( Dept.of pharmaceutical technology).Noisome, a novel drug delivery system:2012.3 -5, 7- 8 ,18- 26.
15.p.pavazhaviji ( Dept.of pharmaceutics,).preparation and application of niosomes :2020.17,19, 26- 27 ,30.
16. k. Arshad Ahmed Khan ( m.pharm, PH.D , Dept.of pharmaceutics).niosomes:2019.10,18-19.
17.Sanjay yadav.niosomes a novel drug delivery system.2014.
18.Siddhartha Mukherjee ( Dept.of pharmaceutics).Proniosomes – A promising Drug carrier:2017.3,5-6,8-10;g.v Radha,T. Sudha, Rani and B. Sravani .
A review on proniosomal drug delivery system for Targeted drug action review article.jBasic Clin Pharm. March 2013-May 2013; 4(2): 42–48.
19.Vyas S.P., Khar R.K., Targeted & Controlled Drug Delivery: Novel Carrier Systems. Pg no. 249-279;Malhotra M., Jain N.K., Niosomes As Drug Carriers. Pg no. 81-86.
20.Malhotra MJain N.Niosomes As Proniosome-derived niosomes for tacrolimus topical ocular delivery: in vitro cornea permeation, ocular irritation, and in vivo anti-allograft rejection. Eur J Pharm Sci. 2014;62:115-123.
21.Alsarra IA, Bosela AA, Ahmed SM, Mahrous GM. (2005). Proniosomes as a drug carrier for transdermal delivery of ketorolac. Eur J Pharm Biopharm, 59, 485-490.
22.Aswathy S, George B J, Samuel J, Raj P, Thomas N, Daisy P A, Carla B: A Review On Proniosomes: An Innovative Approach To Vesicular Drug Delivery System: wjpps:2017:6 (3):1039-1053.
23.Shashikant Sudarshan Upadhye*. Review article American journal of pharmtech research.2020.
24.Shukla N D, Tiwari M: Proniosomal drug delivery systems-Clinical applications, International Journal of Research in Pharmaceutical and Biomedical Sciences: 2014:3(3)275-294.
25.Sudhamani T, Priyadarshini N: Proniosomes: A Promising Drug Carriers, Int J Pharmtech Tech Res:2010:2(2):1446-1454.
26.Shashikant Sudarshan Upadhye*. Review article American journal of pharmtech research.2020.
27.Swati G, Ajay P. Drug Delivery Strategies for Visceral Leishmaniasis, Expert Opin Drug Delivery: 2010:7(3):371-402.
28.Gupta R, Kumar S, Gupta N, Kumar V, Prajapati S K: The proniosomes development and optimization as a surrogate drug carrier for oral delivery of Gliclazide: An-overview, World Journal of Pharmacy and Pharmaceutical Sciences: 2014:3(9):275-294.sss
29.Alli M S, Srilakshmi C H, Ganesan G: Proniosomal Gel: An Effective Novel Therapeutic Topical Delivery System, International Journal of Pharmtech Research:2013:4(5):1754-1764.
30.Shashikant Sudarshan Upadhye*. Review article American journal of pharmtech research.2020.
31.Moser P, Marchand Arvier M, Labrude P, Handjani Vila RM, Vigneron C. Niosomes d’hémoglobine. I Préparation, propriétés physicochimiques et exophoriques, Stabilité. Pharm Acta Helv. 1989;64(7):192-202.
32.Waghmode M, Shruti A: Proniosomal drug delivery systems: An overview, IJPCS:2012: 1(3):1045-1056.